U.Va. Spinoff Announces Collaboration with Pfizer, CIT GAP Fund
Neoantigenics LLC, a new biotechnology company founded on discoveries made by Dr. John Herr at the University of Virginia School of Medicine, announced today it has entered into an early-stage research and development collaboration with Pfizer Inc.
LSU $2M LIFT POC Fund Approved
LSU LIFT, or Leveraging Innovation for Technology Transfer, Fund will support commercialization of faculty intellectual property through small grants for applied research on proof of concept